The European Innovation Council (EIC), established in 2020 and headquartered in Brussels, Belgium, is dedicated to supporting high-potential innovators, entrepreneurs, small enterprises, and researchers. Its primary focus is on fostering early-stage startups that demonstrate significant environmental, social, and governance (ESG) impacts. The EIC collaborates with private investors to co-invest in ventures, particularly within the deep technology sector, aiming to drive innovation and sustainable development across Europe. By providing financial backing and resources, the EIC seeks to enhance the growth potential of promising startups and contribute to a more innovative and competitive European economy.
Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in advanced imaging technologies. The company develops light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. This innovative platform allows for three-dimensional modulation of images across various camera setups, producing volumetric images and videos with enhanced data points and high frame rates. By focusing on improving human interaction with the environment, Wooptix aims to redefine the way users perceive and engage with their surroundings, offering new possibilities for image quality and post-processing capabilities.
INBRAIN Neuroelectronics
Series B in 2024
INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, that specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. Founded in 2019, the company offers the world's first brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation to provide adaptive and personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. Its technology enables continuous real-time monitoring and autonomous adjustments to therapy, enhancing therapeutic outcomes while reducing side effects. INBRAIN is also engaged in strategic collaborations, including with Merck KGaA, to expand its innovative solutions into peripheral nerve and systemic disease applications, thereby advancing the field of neurotechnology and bioelectronics.
Ability Pharmaceuticals
Venture Round in 2024
Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs. Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The company develops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures. Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.
Multiverse Computing
Series A in 2024
Multiverse Computing SL is a software development company based in San Sebastian, Spain, with an additional office in Toronto, Canada. Founded in 2019, the company specializes in creating quantum computing software that addresses complex financial and macro-economic challenges. Its products are tailored for various applications, including portfolio optimization, risk analysis, and market simulation. By leveraging probabilistic and nondeterministic technologies, Multiverse Computing aims to help organizations across diverse sectors such as banking, energy, manufacturing, and logistics navigate the complexities of the second quantum revolution, ultimately providing them with a competitive advantage in their respective industries.
Daze
Series A in 2024
Daze is an engineering startup focused on creating innovative solutions for electric vehicle charging. Its flagship product, DazePlug, is an automatic charging device that utilizes smart charging ecosystems and energy management systems. This technology enables automatic inductive charging, significantly reducing the time required to charge electric vehicles while eliminating the need for manual handling of cables. DazePlug features a retrofit design that is both waterproof and dustproof, ensuring durability and ease of use. By simplifying the charging process, Daze aims to enhance user experience and convenience for electric vehicle owners.
Palobiofarma
Venture Round in 2024
Palobiofarma is a Spanish biotechnology company based in Barcelona's Science Park, dedicated to the discovery and development of new drugs that target adenosine receptors. The company aims to be a leader in adenosine drug discovery in Europe by focusing on innovative therapies. Palobiofarma specializes in creating selective adenosine receptor modulators, with a particular emphasis on addressing advanced prostate cancer. By leveraging medicinal chemistry and in vitro pharmacology, the company is working towards bringing its first marketed drug to the medical community, supporting healthcare professionals in their efforts to treat this challenging disease.
Ignion
Venture Round in 2023
Ignion is an antenna innovator based in Sant Cugat del Vallès, Spain, founded in 2015. The company specializes in manufacturing multiband, multipurpose antennas that cater to mobile and wireless connectivity requirements. Its product offerings include ready-to-use antennas designed for Internet of Things applications and short-range wireless devices, particularly suited for indoor environments. Ignion's solutions allow clients to seamlessly integrate these antennas into their industrial designs, facilitating efficient connectivity in various applications.
INBRAIN Neuroelectronics
Grant in 2023
INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, that specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. Founded in 2019, the company offers the world's first brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation to provide adaptive and personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. Its technology enables continuous real-time monitoring and autonomous adjustments to therapy, enhancing therapeutic outcomes while reducing side effects. INBRAIN is also engaged in strategic collaborations, including with Merck KGaA, to expand its innovative solutions into peripheral nerve and systemic disease applications, thereby advancing the field of neurotechnology and bioelectronics.
Wooptix
Series B in 2023
Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in advanced imaging technologies. The company develops light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. This innovative platform allows for three-dimensional modulation of images across various camera setups, producing volumetric images and videos with enhanced data points and high frame rates. By focusing on improving human interaction with the environment, Wooptix aims to redefine the way users perceive and engage with their surroundings, offering new possibilities for image quality and post-processing capabilities.
Wooptix
Grant in 2023
Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in advanced imaging technologies. The company develops light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. This innovative platform allows for three-dimensional modulation of images across various camera setups, producing volumetric images and videos with enhanced data points and high frame rates. By focusing on improving human interaction with the environment, Wooptix aims to redefine the way users perceive and engage with their surroundings, offering new possibilities for image quality and post-processing capabilities.
ADmit Therapeutics
Venture Round in 2023
ADmit Therapeutics, S.L. is a biotechnology company focused on developing diagnostic tests for the early detection of Alzheimer's disease. Established in 2017 and based in Begues, Spain, the company utilizes an epigenetic analysis of blood samples to identify mitochondrial biomarkers, which are not related to traditional indicators such as ß-amyloid or tau proteins. The test employs next-generation sequencing to analyze various methylcytosines in mitochondrial DNA, providing medical practitioners with an accessible method for detecting early-stage Alzheimer's. This innovative approach not only aids in diagnosis but also supports pharmaceutical companies in accelerating the identification of potential curative treatments.
Daze
Convertible Note in 2022
Daze is an engineering startup focused on creating innovative solutions for electric vehicle charging. Its flagship product, DazePlug, is an automatic charging device that utilizes smart charging ecosystems and energy management systems. This technology enables automatic inductive charging, significantly reducing the time required to charge electric vehicles while eliminating the need for manual handling of cables. DazePlug features a retrofit design that is both waterproof and dustproof, ensuring durability and ease of use. By simplifying the charging process, Daze aims to enhance user experience and convenience for electric vehicle owners.
ELEM Biotech
Pre Seed Round in 2022
ELEM Biotech SL is a biomedical software company based in Barcelona, Spain, that specializes in creating virtual human beings using advanced mathematical modeling and cloud computing. Founded in 2018 by researchers from the Barcelona Supercomputing Center, ELEM has developed Alya Red, a suite of simulation tools designed for the medical device and pharmaceutical industries. Utilizing a Software-as-a-Service model, Alya Red allows for the simulation of cardiovascular and respiratory systems on virtual patients. By integrating high-performance computing, computational biomechanics, and data analysis, ELEM's technology enables biomedical companies and clinicians to improve diagnoses, plan treatments, and optimize drug delivery and medical devices.
INBRAIN Neuroelectronics
Venture Round in 2022
INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, that specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. Founded in 2019, the company offers the world's first brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation to provide adaptive and personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. Its technology enables continuous real-time monitoring and autonomous adjustments to therapy, enhancing therapeutic outcomes while reducing side effects. INBRAIN is also engaged in strategic collaborations, including with Merck KGaA, to expand its innovative solutions into peripheral nerve and systemic disease applications, thereby advancing the field of neurotechnology and bioelectronics.
INBRAIN Neuroelectronics
Grant in 2022
INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, that specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. Founded in 2019, the company offers the world's first brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation to provide adaptive and personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. Its technology enables continuous real-time monitoring and autonomous adjustments to therapy, enhancing therapeutic outcomes while reducing side effects. INBRAIN is also engaged in strategic collaborations, including with Merck KGaA, to expand its innovative solutions into peripheral nerve and systemic disease applications, thereby advancing the field of neurotechnology and bioelectronics.
ELEM Biotech
Grant in 2022
ELEM Biotech SL is a biomedical software company based in Barcelona, Spain, that specializes in creating virtual human beings using advanced mathematical modeling and cloud computing. Founded in 2018 by researchers from the Barcelona Supercomputing Center, ELEM has developed Alya Red, a suite of simulation tools designed for the medical device and pharmaceutical industries. Utilizing a Software-as-a-Service model, Alya Red allows for the simulation of cardiovascular and respiratory systems on virtual patients. By integrating high-performance computing, computational biomechanics, and data analysis, ELEM's technology enables biomedical companies and clinicians to improve diagnoses, plan treatments, and optimize drug delivery and medical devices.
Abzu
Grant in 2022
Abzu is a scientific artificial intelligence company founded in January 2018, with offices in Copenhagen, Denmark, and Barcelona, Spain. The company develops the QLattice, an innovative AI platform that aims to challenge conventional black box AI by providing transparent and explainable models. Abzu's technology is designed to assist pharmaceutical and biotech companies in accelerating drug development processes. By unlocking new disease mechanisms, discovering novel biomarkers, and validating multiple targets simultaneously, Abzu enables these companies to reduce research and development costs and enhance their discovery capabilities. Through its pioneering approach, Abzu inspires data scientists to adopt a more scientific methodology in their work.
SiPearl
Series A in 2022
SiPearl is a French semiconductor company established in 2019, headquartered in Maisons-Laffitte, Île-de-France, with research and development centers located in France, Germany, and Spain. The company specializes in the design of high-performance, low-power microprocessors intended for exascale supercomputers, aligning its product development with the European Union’s technological goals. Its first microprocessor range, Rhea, is set for commercialization in early 2024 and is based on the Arm Neoverse V1 architecture. SiPearl is committed to manufacturing Rhea using advanced processes from TSMC, ensuring state-of-the-art performance. The microprocessors are aimed at a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, serving scientific researchers and major players in the IT, electronics, and automotive sectors.
SiPearl
Grant in 2022
SiPearl is a French semiconductor company established in 2019, headquartered in Maisons-Laffitte, Île-de-France, with research and development centers located in France, Germany, and Spain. The company specializes in the design of high-performance, low-power microprocessors intended for exascale supercomputers, aligning its product development with the European Union’s technological goals. Its first microprocessor range, Rhea, is set for commercialization in early 2024 and is based on the Arm Neoverse V1 architecture. SiPearl is committed to manufacturing Rhea using advanced processes from TSMC, ensuring state-of-the-art performance. The microprocessors are aimed at a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, serving scientific researchers and major players in the IT, electronics, and automotive sectors.
Ignion
Grant in 2022
Ignion is an antenna innovator based in Sant Cugat del Vallès, Spain, founded in 2015. The company specializes in manufacturing multiband, multipurpose antennas that cater to mobile and wireless connectivity requirements. Its product offerings include ready-to-use antennas designed for Internet of Things applications and short-range wireless devices, particularly suited for indoor environments. Ignion's solutions allow clients to seamlessly integrate these antennas into their industrial designs, facilitating efficient connectivity in various applications.
Ignion
Venture Round in 2022
Ignion is an antenna innovator based in Sant Cugat del Vallès, Spain, founded in 2015. The company specializes in manufacturing multiband, multipurpose antennas that cater to mobile and wireless connectivity requirements. Its product offerings include ready-to-use antennas designed for Internet of Things applications and short-range wireless devices, particularly suited for indoor environments. Ignion's solutions allow clients to seamlessly integrate these antennas into their industrial designs, facilitating efficient connectivity in various applications.
SAALG Geomechanics
Venture Round in 2022
SAALG Geomechanics SL, founded in 2016 and based in Barcelona, Spain, specializes in developing software for real-time analysis of ground conditions during civil engineering projects. The company provides advanced geological and numerical services, including numerical model calibrations and characterization of soil and rock parameters through back-analysis and inverse analysis. Its offerings include 2D and 3D geomechanical and geotechnical simulations, primarily focused on applications such as tunnel excavations, large and deep excavations, reinforced earth retaining walls, and wellbore stability analysis. By leveraging machine learning and real-time data analysis technology, SAALG Geomechanics enables construction companies to anticipate potential risks associated with ground movement, thereby optimizing project management, minimizing risks, and enhancing efficiency.
SAALG Geomechanics
Grant in 2022
SAALG Geomechanics SL, founded in 2016 and based in Barcelona, Spain, specializes in developing software for real-time analysis of ground conditions during civil engineering projects. The company provides advanced geological and numerical services, including numerical model calibrations and characterization of soil and rock parameters through back-analysis and inverse analysis. Its offerings include 2D and 3D geomechanical and geotechnical simulations, primarily focused on applications such as tunnel excavations, large and deep excavations, reinforced earth retaining walls, and wellbore stability analysis. By leveraging machine learning and real-time data analysis technology, SAALG Geomechanics enables construction companies to anticipate potential risks associated with ground movement, thereby optimizing project management, minimizing risks, and enhancing efficiency.
Multiverse Computing
Venture Round in 2021
Multiverse Computing SL is a software development company based in San Sebastian, Spain, with an additional office in Toronto, Canada. Founded in 2019, the company specializes in creating quantum computing software that addresses complex financial and macro-economic challenges. Its products are tailored for various applications, including portfolio optimization, risk analysis, and market simulation. By leveraging probabilistic and nondeterministic technologies, Multiverse Computing aims to help organizations across diverse sectors such as banking, energy, manufacturing, and logistics navigate the complexities of the second quantum revolution, ultimately providing them with a competitive advantage in their respective industries.
Multiverse Computing
Grant in 2021
Multiverse Computing SL is a software development company based in San Sebastian, Spain, with an additional office in Toronto, Canada. Founded in 2019, the company specializes in creating quantum computing software that addresses complex financial and macro-economic challenges. Its products are tailored for various applications, including portfolio optimization, risk analysis, and market simulation. By leveraging probabilistic and nondeterministic technologies, Multiverse Computing aims to help organizations across diverse sectors such as banking, energy, manufacturing, and logistics navigate the complexities of the second quantum revolution, ultimately providing them with a competitive advantage in their respective industries.
Aortyx
Grant in 2021
Aortyx is a pioneering company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona, dedicated to developing innovative endovascular devices for the treatment of vascular diseases. The company specializes in technology that promotes tissue regeneration by closely mimicking the biomechanical environment of the aorta. Its devices are designed to create a favorable environment for cell migration and proliferation, utilizing a bioresorbable platform that closely replicates the natural dynamics of the aorta. This approach aims to enhance the effectiveness of treatments for aortic diseases, providing healthcare professionals with advanced solutions for managing these conditions.
CARTO
Series C in 2021
CARTO is a leading Location Intelligence platform that specializes in transforming spatial data into actionable insights for businesses. Founded in 2012 by an environmental scientist and visualization experts, the company is headquartered in New York City, with additional offices in Madrid, Seville, and Washington, DC. CARTO provides a cloud-based mapping, analysis, and visualization engine that enables data scientists, developers, and analysts to tackle spatial problems, optimize business processes, and predict outcomes. Its services facilitate more efficient delivery routes, enhanced behavioral marketing, and strategic store placements. With a customer base of 2,500, including notable companies like Mastercard, Vodafone, and Coca-Cola, CARTO has established itself as a significant player in the field. The company employs around 130 people and has garnered recognition from industry leaders such as G2, Gartner, and Forrester for its innovative contributions to Location Intelligence.
Daze
Seed Round in 2021
Daze is an engineering startup focused on creating innovative solutions for electric vehicle charging. Its flagship product, DazePlug, is an automatic charging device that utilizes smart charging ecosystems and energy management systems. This technology enables automatic inductive charging, significantly reducing the time required to charge electric vehicles while eliminating the need for manual handling of cables. DazePlug features a retrofit design that is both waterproof and dustproof, ensuring durability and ease of use. By simplifying the charging process, Daze aims to enhance user experience and convenience for electric vehicle owners.
MYSPHERA
Grant in 2021
MYSPHERA SL is a company based in Paterna, Spain, that specializes in developing location and process visibility solutions for the healthcare sector using Internet of Things (IoT) technology and real-time location systems (RTLS). Established in 2012, MYSPHERA offers a range of IoT devices and applications designed to enhance patient care and operational efficiency in acute care hospitals, senior living facilities, and patient homes. Its solutions include tracking systems for residents and nursing services, as well as alerts for patients. The company also provides various web applications, such as MYHOSPITAL, MYNURSING, and MYLOCS, which assist healthcare professionals and administrators in managing services effectively. By delivering actionable insights through smart sensors, MYSPHERA aims to improve patient outcomes and optimize resource management across healthcare organizations in Europe, the Middle East, and Latin America.
Palobiofarma
Grant in 2021
Palobiofarma is a Spanish biotechnology company based in Barcelona's Science Park, dedicated to the discovery and development of new drugs that target adenosine receptors. The company aims to be a leader in adenosine drug discovery in Europe by focusing on innovative therapies. Palobiofarma specializes in creating selective adenosine receptor modulators, with a particular emphasis on addressing advanced prostate cancer. By leveraging medicinal chemistry and in vitro pharmacology, the company is working towards bringing its first marketed drug to the medical community, supporting healthcare professionals in their efforts to treat this challenging disease.
Palobiofarma
Venture Round in 2021
Palobiofarma is a Spanish biotechnology company based in Barcelona's Science Park, dedicated to the discovery and development of new drugs that target adenosine receptors. The company aims to be a leader in adenosine drug discovery in Europe by focusing on innovative therapies. Palobiofarma specializes in creating selective adenosine receptor modulators, with a particular emphasis on addressing advanced prostate cancer. By leveraging medicinal chemistry and in vitro pharmacology, the company is working towards bringing its first marketed drug to the medical community, supporting healthcare professionals in their efforts to treat this challenging disease.
Wooptix
Venture Round in 2021
Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in advanced imaging technologies. The company develops light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. This innovative platform allows for three-dimensional modulation of images across various camera setups, producing volumetric images and videos with enhanced data points and high frame rates. By focusing on improving human interaction with the environment, Wooptix aims to redefine the way users perceive and engage with their surroundings, offering new possibilities for image quality and post-processing capabilities.
SiPearl
Venture Round in 2021
SiPearl is a French semiconductor company established in 2019, headquartered in Maisons-Laffitte, Île-de-France, with research and development centers located in France, Germany, and Spain. The company specializes in the design of high-performance, low-power microprocessors intended for exascale supercomputers, aligning its product development with the European Union’s technological goals. Its first microprocessor range, Rhea, is set for commercialization in early 2024 and is based on the Arm Neoverse V1 architecture. SiPearl is committed to manufacturing Rhea using advanced processes from TSMC, ensuring state-of-the-art performance. The microprocessors are aimed at a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, serving scientific researchers and major players in the IT, electronics, and automotive sectors.
SiPearl
Grant in 2021
SiPearl is a French semiconductor company established in 2019, headquartered in Maisons-Laffitte, Île-de-France, with research and development centers located in France, Germany, and Spain. The company specializes in the design of high-performance, low-power microprocessors intended for exascale supercomputers, aligning its product development with the European Union’s technological goals. Its first microprocessor range, Rhea, is set for commercialization in early 2024 and is based on the Arm Neoverse V1 architecture. SiPearl is committed to manufacturing Rhea using advanced processes from TSMC, ensuring state-of-the-art performance. The microprocessors are aimed at a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, serving scientific researchers and major players in the IT, electronics, and automotive sectors.
Spika Tech
Venture Round in 2021
Spika Tech is a Madrid-based company established in 2015, focused on research and development in the technological sector. The company provides a range of services aimed at assisting businesses with their projects, including virtual reality, augmented reality, complex software application development, and artificial intelligence. Additionally, Spika Tech specializes in creating logos, corporate identities, presentations, websites, applications, and online stores. By leveraging the latest techniques in design and programming, Spika Tech aims to enhance the quality of development processes for its clients.
Wooptix
Grant in 2021
Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in advanced imaging technologies. The company develops light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. This innovative platform allows for three-dimensional modulation of images across various camera setups, producing volumetric images and videos with enhanced data points and high frame rates. By focusing on improving human interaction with the environment, Wooptix aims to redefine the way users perceive and engage with their surroundings, offering new possibilities for image quality and post-processing capabilities.
Spika Tech
Grant in 2021
Spika Tech is a Madrid-based company established in 2015, focused on research and development in the technological sector. The company provides a range of services aimed at assisting businesses with their projects, including virtual reality, augmented reality, complex software application development, and artificial intelligence. Additionally, Spika Tech specializes in creating logos, corporate identities, presentations, websites, applications, and online stores. By leveraging the latest techniques in design and programming, Spika Tech aims to enhance the quality of development processes for its clients.
MYSPHERA
Venture Round in 2021
MYSPHERA SL is a company based in Paterna, Spain, that specializes in developing location and process visibility solutions for the healthcare sector using Internet of Things (IoT) technology and real-time location systems (RTLS). Established in 2012, MYSPHERA offers a range of IoT devices and applications designed to enhance patient care and operational efficiency in acute care hospitals, senior living facilities, and patient homes. Its solutions include tracking systems for residents and nursing services, as well as alerts for patients. The company also provides various web applications, such as MYHOSPITAL, MYNURSING, and MYLOCS, which assist healthcare professionals and administrators in managing services effectively. By delivering actionable insights through smart sensors, MYSPHERA aims to improve patient outcomes and optimize resource management across healthcare organizations in Europe, the Middle East, and Latin America.
INBRAIN Neuroelectronics
Grant in 2021
INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, that specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. Founded in 2019, the company offers the world's first brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation to provide adaptive and personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. Its technology enables continuous real-time monitoring and autonomous adjustments to therapy, enhancing therapeutic outcomes while reducing side effects. INBRAIN is also engaged in strategic collaborations, including with Merck KGaA, to expand its innovative solutions into peripheral nerve and systemic disease applications, thereby advancing the field of neurotechnology and bioelectronics.
Daze
Venture Round in 2020
Daze is an engineering startup focused on creating innovative solutions for electric vehicle charging. Its flagship product, DazePlug, is an automatic charging device that utilizes smart charging ecosystems and energy management systems. This technology enables automatic inductive charging, significantly reducing the time required to charge electric vehicles while eliminating the need for manual handling of cables. DazePlug features a retrofit design that is both waterproof and dustproof, ensuring durability and ease of use. By simplifying the charging process, Daze aims to enhance user experience and convenience for electric vehicle owners.
X1 Wind
Grant in 2020
X1 Wind is a Barcelona-based company focused on developing innovative floating wind platforms designed for deep-water offshore wind energy. Founded in 2017, the company has engineered a floating system that significantly reduces costs by 50% and weight by 80% compared to traditional floating solutions. Its design minimizes the number of active systems, allowing for simplified installation and maintenance. The platform can be fully assembled at the port and deployed using a small tug boat, enhancing operational efficiency. X1 Wind's technology aims to provide a scalable and sustainable energy solution, contributing to the global transition toward clean and affordable energy while also helping to reduce carbon emissions.
Unblur
Grant in 2020
Unblur is a technology company based in Barcelona, Spain, founded in 2015, that focuses on developing AI software for public emergency services, including firefighters, civil protection, and police. Its primary offering is IRIS, a modular software-as-a-service platform designed to enhance incident command. The platform centralizes data and tools, providing incident commanders with real-time situational awareness throughout the various stages of an incident. This capability enables emergency service organizations to improve their operational response and make informed decisions during critical situations, ultimately enhancing coordination among teams and effectiveness in emergency management.
Unblur
Venture Round in 2020
Unblur is a technology company based in Barcelona, Spain, founded in 2015, that focuses on developing AI software for public emergency services, including firefighters, civil protection, and police. Its primary offering is IRIS, a modular software-as-a-service platform designed to enhance incident command. The platform centralizes data and tools, providing incident commanders with real-time situational awareness throughout the various stages of an incident. This capability enables emergency service organizations to improve their operational response and make informed decisions during critical situations, ultimately enhancing coordination among teams and effectiveness in emergency management.
Ability Pharmaceuticals
Grant in 2020
Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs. Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The company develops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures. Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.
ADmit Therapeutics
Grant in 2020
ADmit Therapeutics, S.L. is a biotechnology company focused on developing diagnostic tests for the early detection of Alzheimer's disease. Established in 2017 and based in Begues, Spain, the company utilizes an epigenetic analysis of blood samples to identify mitochondrial biomarkers, which are not related to traditional indicators such as ß-amyloid or tau proteins. The test employs next-generation sequencing to analyze various methylcytosines in mitochondrial DNA, providing medical practitioners with an accessible method for detecting early-stage Alzheimer's. This innovative approach not only aids in diagnosis but also supports pharmaceutical companies in accelerating the identification of potential curative treatments.
CARTO
Grant in 2020
CARTO is a leading Location Intelligence platform that specializes in transforming spatial data into actionable insights for businesses. Founded in 2012 by an environmental scientist and visualization experts, the company is headquartered in New York City, with additional offices in Madrid, Seville, and Washington, DC. CARTO provides a cloud-based mapping, analysis, and visualization engine that enables data scientists, developers, and analysts to tackle spatial problems, optimize business processes, and predict outcomes. Its services facilitate more efficient delivery routes, enhanced behavioral marketing, and strategic store placements. With a customer base of 2,500, including notable companies like Mastercard, Vodafone, and Coca-Cola, CARTO has established itself as a significant player in the field. The company employs around 130 people and has garnered recognition from industry leaders such as G2, Gartner, and Forrester for its innovative contributions to Location Intelligence.
ADmit Therapeutics
Venture Round in 2020
ADmit Therapeutics, S.L. is a biotechnology company focused on developing diagnostic tests for the early detection of Alzheimer's disease. Established in 2017 and based in Begues, Spain, the company utilizes an epigenetic analysis of blood samples to identify mitochondrial biomarkers, which are not related to traditional indicators such as ß-amyloid or tau proteins. The test employs next-generation sequencing to analyze various methylcytosines in mitochondrial DNA, providing medical practitioners with an accessible method for detecting early-stage Alzheimer's. This innovative approach not only aids in diagnosis but also supports pharmaceutical companies in accelerating the identification of potential curative treatments.
AEInnova
Series A in 2020
AEInnova, founded in 2014 at the Autonomous University of Barcelona, specializes in innovative Internet of Things (IoT) solutions for predictive maintenance. The company was established by a team of PhDs and engineers with expertise in microelectronics and various engineering disciplines. AEInnova's flagship product, InduEye, is a fully battery-less and autonomous device that monitors vibrations, steam traps, and thermal conditions, harnessing energy from waste heat, with future versions incorporating solar and wind power. The technology stands out due to its patented innovation, which enhances performance and enables real-time edge computing while utilizing advanced wireless communication standards. AEInnova's devices are employed in diverse sectors, including oil and gas, aluminum, steel, paper, and water treatment, and feature a sophisticated IoT cloud-based dashboard for data analytics and predictive maintenance. The company has received 31 international awards for its contributions to sustainability and innovation and has secured significant investment, including funding from the European Commission. AEInnova is actively engaged in multiple EU R&D projects focused on energy harvesting and IoT technologies.
Ability Pharmaceuticals
Grant in 2020
Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs. Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The company develops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures. Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.
AEInnova
Grant in 2019
AEInnova, founded in 2014 at the Autonomous University of Barcelona, specializes in innovative Internet of Things (IoT) solutions for predictive maintenance. The company was established by a team of PhDs and engineers with expertise in microelectronics and various engineering disciplines. AEInnova's flagship product, InduEye, is a fully battery-less and autonomous device that monitors vibrations, steam traps, and thermal conditions, harnessing energy from waste heat, with future versions incorporating solar and wind power. The technology stands out due to its patented innovation, which enhances performance and enables real-time edge computing while utilizing advanced wireless communication standards. AEInnova's devices are employed in diverse sectors, including oil and gas, aluminum, steel, paper, and water treatment, and feature a sophisticated IoT cloud-based dashboard for data analytics and predictive maintenance. The company has received 31 international awards for its contributions to sustainability and innovation and has secured significant investment, including funding from the European Commission. AEInnova is actively engaged in multiple EU R&D projects focused on energy harvesting and IoT technologies.
AEInnova
Seed Round in 2019
AEInnova, founded in 2014 at the Autonomous University of Barcelona, specializes in innovative Internet of Things (IoT) solutions for predictive maintenance. The company was established by a team of PhDs and engineers with expertise in microelectronics and various engineering disciplines. AEInnova's flagship product, InduEye, is a fully battery-less and autonomous device that monitors vibrations, steam traps, and thermal conditions, harnessing energy from waste heat, with future versions incorporating solar and wind power. The technology stands out due to its patented innovation, which enhances performance and enables real-time edge computing while utilizing advanced wireless communication standards. AEInnova's devices are employed in diverse sectors, including oil and gas, aluminum, steel, paper, and water treatment, and feature a sophisticated IoT cloud-based dashboard for data analytics and predictive maintenance. The company has received 31 international awards for its contributions to sustainability and innovation and has secured significant investment, including funding from the European Commission. AEInnova is actively engaged in multiple EU R&D projects focused on energy harvesting and IoT technologies.
X1 Wind
Seed Round in 2019
X1 Wind is a Barcelona-based company focused on developing innovative floating wind platforms designed for deep-water offshore wind energy. Founded in 2017, the company has engineered a floating system that significantly reduces costs by 50% and weight by 80% compared to traditional floating solutions. Its design minimizes the number of active systems, allowing for simplified installation and maintenance. The platform can be fully assembled at the port and deployed using a small tug boat, enhancing operational efficiency. X1 Wind's technology aims to provide a scalable and sustainable energy solution, contributing to the global transition toward clean and affordable energy while also helping to reduce carbon emissions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.